Jiangsu Keygen Biotech Co., Ltd.

Jiangsu KeyGEN BioTECH Co., Ltd. is a high-tech enterprise and National branded supplier specializing in developing bio-reagent Products and biotechnology services, focusing on life science Research and diagnostic translational medicine. Relying on core technologies, such as high purity and high active Protein expression, KeyGEN has covered the whole industry chain, From the development of raw materials to product circulation in The bio-reagent industry. KeyGEN has formed a complete and Independent system of production and marketing for research Reagents and diagnostic products. Also, some core raw materials Have been "independent and controllable. " KeyGEN invests 15% of Its annual operating revenue in the R&D of bio-reagent and owns Tens of innovation patents, including seven international patents in The U. S., Japan, and Europe. KeyGEN has also earned the ISO9001 Quality management system certification, ISO13485 quality Management system certification, GB/T29490-2013 intellectual Property management system certification for its products and Services. Moreover, KeyGEN is the operator of several common Technology platforms, including the Jiangsu Diagnostic Reagent Research Center, Jiangsu Bio-Medicine Public Service Platform,

Nanjing Diagnostics, and Translational Medicine Public Technology Service Platform, China-UK TOF-MS Diagnostic Technology Center, etc.

In recent years, KeyGEN BioTECH has been improving the function Layout of upstream and downstream industry chains in the

Bio-reagent industry. Through cooperation with the local government, KeyGEN has Cultivated the subsidiary brand, "TITECA, " focusing on the planning And operation of life science common platform. Until now, KeyGEN Has provided thousands of users with high-quality, professional Scientific and technological services and has completed the Industrial incubation for hundreds of high-tech talents at home And abroad. With the clustering of high-tech enterprises in the TITECA project and the leading, professional standard operation,

Our company will further play the advantage of the "KeyGEN" and "TITECA" double platform. KeyGEN will continue to develop new Technologies and new products to improve product development And manufacturing efficiency. Furthermore, KeyGEN will help more R&D innovation and entrepreneurship in the New Medicine and Healthcare industry, realizing the industrialization of more Self-controlled scientific and technological achievements.

Self-controlled scientifific and technological achievements.